ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 24 Issue : 5
Current Issue Archive Popular Article Ahead of Print

 
Sex-specific associations of TCF7L2 variants with fasting glucose, type 2 diabetes and coronary heart disease among Turkish adults [Anatol J Cardiol]
Anatol J Cardiol. 2020; 24(5): 326-333 | DOI: 10.14744/AnatolJCardiol.2020.57736  

Sex-specific associations of TCF7L2 variants with fasting glucose, type 2 diabetes and coronary heart disease among Turkish adults

Ayşe Berna Yüzbaşıoğulları1, Evrim Kömürcü-bayrak1, Altan Onat2, Gunay Can3, Nina Mononen4, Reijo Laaksonen4, Mika Kähönen5, Terho Lehtimäki4, Nihan Erginel-ünaltuna1
1Department of Genetics, Aziz Sancar Institute for Experimental Medicine, İstanbul University; İstanbul-Turkey
2Emeritus Professor, Department of Cardiology, Cerrahpaşa Faculty of Medicine, İstanbul University; İstanbul-Turkey
3Department of Public Health, Cerrahpaşa Faculty of Medicine, İstanbul University; İstanbul-Turkey
4Department of Clinical Chemistry, Fimlab Laboratories, and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere; Tampere-Finland
5Department of Clinical Physiology, Tampere University Hospital, and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere; Tampere-Finland

Objective: TCF7L2 is a repressor and transactivator of genes, and its variants are strongly associated with diabetes. This study aimed to evaluate the sex-specific relationship between the most common TCF7L2 gene variants (-98368G>T, rs12255372 and -47833C>T, rs7903146) with diabetes and coronary heart disease in Turkish Adult Risk Factor (TARF) Study.
Methods: Single nucleotide variants (SNVs) have been genotyped using the TaqMan allelic discrimination assays in 2,024 (51.3% in women, age: 55±11.8) Turkish adults participating in the TARF study. Statistical analyses were used to investigate the association of genotypes with clinical and biochemical measurements.
Results: Among the TARF study participants, 11.7%, 24.3%, 14.1%, and 38.3% had diabetes, hypertension, coronary heart disease (CHD), and obesity, respectively. The frequencies of T allele for -47833C>T and -98368G>T in Turkish adults were determined to be 0.35 and 0.33, respectively. -47833C>T was significantly associated with higher fasting glucose concentrations in all participants, especially in men. Both SNVs were significantly associated with diabetes and CHD in all participants (p<0.05). When study population was stratified according to sex, -98368G>T was associated with diabetes in women (p=0.041) and -47833C>T was associated with diabetes and CHD in men (p=0.018 and p=0.032, respectively). Also, both SNVs and the diplotypes of common haplotype (H1) remained strongly associated with type 2 diabetes after risk factors were adjusted (p<0.05).
Conclusion: T allele homozygosity of two SNVs as well as the diplotype H1-/H1- reflects risk of diabetes primarily in men. Enhanced CHD risk is determined by the presence of diplotype H1-/H1- among nondiabetic participants.

Keywords: TCF7L2, variants, type 2 diabetes, coronary heart disease, TARF study


Ayşe Berna Yüzbaşıoğulları, Evrim Kömürcü-bayrak, Altan Onat, Gunay Can, Nina Mononen, Reijo Laaksonen, Mika Kähönen, Terho Lehtimäki, Nihan Erginel-ünaltuna. Sex-specific associations of TCF7L2 variants with fasting glucose, type 2 diabetes and coronary heart disease among Turkish adults. Anatol J Cardiol. 2020; 24(5): 326-333

Corresponding Author: Nihan Erginel-ünaltuna, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2019 Turkish Society of Cardiology